GB201918290D0 - Method - Google Patents

Method

Info

Publication number
GB201918290D0
GB201918290D0 GBGB1918290.6A GB201918290A GB201918290D0 GB 201918290 D0 GB201918290 D0 GB 201918290D0 GB 201918290 A GB201918290 A GB 201918290A GB 201918290 D0 GB201918290 D0 GB 201918290D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1918290.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achilles Therapeutics PLC
Original Assignee
Achilles Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achilles Therapeutics PLC filed Critical Achilles Therapeutics PLC
Priority to GBGB1918290.6A priority Critical patent/GB201918290D0/en
Publication of GB201918290D0 publication Critical patent/GB201918290D0/en
Priority to AU2020400079A priority patent/AU2020400079A1/en
Priority to EP20824325.3A priority patent/EP4073267A1/en
Priority to JP2022536499A priority patent/JP2023505726A/en
Priority to PCT/GB2020/053201 priority patent/WO2021116714A1/en
Priority to CA3161070A priority patent/CA3161070A1/en
Priority to KR1020227023292A priority patent/KR20220116475A/en
Priority to US17/784,324 priority patent/US20230052157A1/en
Priority to CN202080086034.0A priority patent/CN114787381A/en
Ceased legal-status Critical Current

Links

GBGB1918290.6A 2019-12-12 2019-12-12 Method Ceased GB201918290D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1918290.6A GB201918290D0 (en) 2019-12-12 2019-12-12 Method
AU2020400079A AU2020400079A1 (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acid for sequencing
EP20824325.3A EP4073267A1 (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acid for sequencing
JP2022536499A JP2023505726A (en) 2019-12-12 2020-12-11 Methods of obtaining nucleic acids for sequencing
PCT/GB2020/053201 WO2021116714A1 (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acid for sequencing
CA3161070A CA3161070A1 (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acid for sequencing
KR1020227023292A KR20220116475A (en) 2019-12-12 2020-12-11 Methods for obtaining nucleic acids for sequencing
US17/784,324 US20230052157A1 (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acid for sequencing
CN202080086034.0A CN114787381A (en) 2019-12-12 2020-12-11 Method for obtaining nucleic acids for sequencing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1918290.6A GB201918290D0 (en) 2019-12-12 2019-12-12 Method

Publications (1)

Publication Number Publication Date
GB201918290D0 true GB201918290D0 (en) 2020-01-29

Family

ID=69186557

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1918290.6A Ceased GB201918290D0 (en) 2019-12-12 2019-12-12 Method

Country Status (1)

Country Link
GB (1) GB201918290D0 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140120622A1 (en) 2012-10-10 2014-05-01 Sangamo Biosciences, Inc. T cell modifying compounds and uses thereof
WO2019012296A1 (en) 2017-07-14 2019-01-17 The Francis Crick Institute Limited Analysis of hla alleles in tumours and the uses thereof
WO2019094642A1 (en) 2017-11-08 2019-05-16 Neon Therapeutics, Inc. T cell manufacturing compositions and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140120622A1 (en) 2012-10-10 2014-05-01 Sangamo Biosciences, Inc. T cell modifying compounds and uses thereof
WO2019012296A1 (en) 2017-07-14 2019-01-17 The Francis Crick Institute Limited Analysis of hla alleles in tumours and the uses thereof
WO2019094642A1 (en) 2017-11-08 2019-05-16 Neon Therapeutics, Inc. T cell manufacturing compositions and methods

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ARES ET AL., COLD SPRING HARB PROTOC., vol. 11, 3 November 2014 (2014-11-03), pages 1139 - 48
BOA ET AL., CANCER INFORMATICS., vol. 13, no. 2, 2014, pages 67 - 82
HALEMARHAM: "THE HARPER COLLINS DICTIONARY OF BIOLOGY", 1991, HARPER PERENNIAL
KAMMERMEIER ET AL., J MED GENET., vol. 51, no. 11, November 2014 (2014-11-01), pages 748 - 55
KOBOLDT ET AL., GENOME RES., vol. 22, 2012, pages 568 - 576
LANDAU ET AL., CELL, vol. 152, no. 4, 14 February 2013 (2013-02-14), pages 714 - 26
MARDIS, ANNU REV ANAL CHEM, 2013
MEYERSON ET AL., NAT. REV. GENETICS, 2010
SINGLETON ET AL.: "DICTIONARY OF MICROBIOLOGY AND MOLECULAR BIOLOGY", 1994, JOHN WILEY AND SONS
VAN LOO ET AL., PNAS, vol. 107, no. 39, 2010, pages 16910 - 16915
YAP KL ET AL., CLIN CANCER RES., vol. 20, 2014, pages 6605

Similar Documents

Publication Publication Date Title
SG11202112409WA (en) Method
GB201909562D0 (en) Method
GB201911286D0 (en) Method
GB201910759D0 (en) Method
GB201917742D0 (en) Method
GB201912863D0 (en) Novel method
GB201900940D0 (en) Method
GB201900647D0 (en) Method
GB201917060D0 (en) Method
GB201913997D0 (en) Method
GB201907782D0 (en) Method
GB201901532D0 (en) Method
GB2587925B (en) Method
IL289648A (en) Method
GB2587178B (en) Method
EP4038198C0 (en) Method
GB202007297D0 (en) Method
GB201918290D0 (en) Method
GB201917806D0 (en) Method
GB201917824D0 (en) Method
GB201917638D0 (en) Method
GB201917599D0 (en) Method
GB201916390D0 (en) Method
GB201916388D0 (en) Method
GB201916077D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)